|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 800 I STREET, NW |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3173-12
|
||||||||
|
6. House ID# 333530000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Donald Hoppert |
Date | 10/19/2021 2:14:30 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Support the inclusion of the Public Health Infrastructure Saves Lives Act in infrastructure/jobs legislation.
Support the House FY 2022 Labor-HHS-Education appropriations bill.
Support $110 million for CDC's Climate and Health Program in FY 2022.
Support $50 million in FY 2022 for gun violence prevention research at CDC and NIH.
Support $322 million for CDC's National Center for Environmental Health in FY 2022.
Support $93 million for the Agency for Toxic Substances and Disease Registry in FY 2022.
Support support of full funding of immunization-related activities at the Department of Health and Human Services.
Support $750 million for the Title V Maternal and Child Health (MCH) Services Block Grant in FY22.
Support $1.51 billion for the Health Resources and Services Administration (HRSA) Title VII health professions and Title VIII nursing workforce development programs in FY 2022.
Support $101.8 million for Public Health and Preventive Medicine residency funding in FY 2022.
Support $200 million for federal school-based health center funding in FY 2022.
Support $250 million in FY 2022 for the public health Data Modernization Initiative at CDC.
Support $153 million in funding for CDC's Social Determinants of Health Program in FY 2022.
Support adequate funding for maternal health programs at CDC, HRSA and NIH in fiscal year 2022.
Support $737 million in funding for the Title X Family Planning program in fiscal year 2022.
Support adequate FY22 discretionary funding for global health programs.
Support increased funding for the Teen Pregnancy Prevention program and other sexual health programs at CDC in fiscal year 2023.
Support $512 million in funding for the Title X family planning program in the President's budget for fiscal year 2023.
Support strong nutrition and tobacco regulations in reconciliation legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Support the S. 674, the Public Health Infrastructure Saves Lives Act.
Support H.R. 3297, the Public Health Workforce Loan Repayment Act of 2021.
Support the Protecting Seniors Through Immunization Act of 2021.
Support for child nutrition programs that ensure vulnerable families receive nutritious meals for their children during and after the COVID-19 pandemic.
Support the Black Maternal Health Momnibus Act.
Support the inclusion of health care provisions focused on equity, true affordability, coverage, and system change in reconciliation legislation.
Support strong children's nutrition provisions including school meal nutrition standards in Child Nutrition Reauthorization legislation.
Support S. 1675, the Maternal Health Quality Improvement Act.
Support S. 1279, the Access to Healthy Food for Young Children Act.
Support S. 1530/H.R. 3115, the Universal School Meals Program Act.
Support H.R. 3149/S. 1660, the HEAL for Immigrant Families Act.
Support H.R. 3755, the Women's Health Protection Act.
Support H.R. 3467, the Improving Data Collection for Adverse Childhood Experiences Act.
Support the Medicaid is Your Right Act.
Support the Child Suicide Prevention and Lethal Means Safety Act.
Support the Early Childhood Nutrition Improvement Act.
Support the LIFT the BAR Act.
Support the MOMMAs Act (H.R.3407/S.411) or the MOMMIES Act (H.R.3063/S.1542).
Support investments that direct resources to community-based organizations to address the racial inequities of maternal health through culturally congruent, place-based caregiving.
Support S. 2691, the Strengthening the Vaccines for Children Program Act of 2021.
Support inclusion of 12-month continuous eligibility for Medicaid and the Children's Health Insurance Program in upcoming reconciliation legislation.
Support H.R. 955/S.285, the Medicaid Reentry Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Vice President of the U.S., White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Support for a universal, comprehensive paid leave policy as part of budget reconciliation legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Support H.R. 2786/S. 1314, the Tobacco Tax Equity Act.
Support for the tobacco tax provisions included in the portion of the Build Back Better Act.
Oppose any language weakening FDA authority over tobacco in FY 2022 appropriations legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Support for transportation policies that reduce both harmful air pollution and climate pollution.
Support of including the safety advances included in H.R. 3684, the INVEST in America Act in any final infrastructure legislation.
Support H.R. 3684, the INVEST in America Act.
Support of including the safety advances included in H.R. 3684, the INVEST in America Act in any final infrastructure legislation
Support S. 2888, U.S. Air Travel Public Safety Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Support H.R. 5/S. 393, the Equality Act.
Support H.R. 1280, the George Floyd Justice in Policing Act of 2021.
Support the John Lewis Voting Rights Advancement Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Support H.R. 8, the Bipartisan Background Checks Act of 2021, and S. 529, the Background Check Expansion Act.
Support H.R. 1446, the Enhanced Background Checks Act of 2021.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Support for the nomination of Rahul Gupta, MD, MPH, MBA, FACP as director of the Office of National Drug Control Policy.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Support including $45 billion in federal funding in infrastructure legislation to fully replace all lead service lines in the nation.
Support for the inclusion of strong climate change, clean energy and environmental justice provisions in budget reconciliation legislation.
Support H.R. 3721/S. 1702, the Climate Change Health Protection and Promotion Act of 2021.
Support for maximizing funding for zero-emission school buses in infrastructure legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Support Safer Prescribing of Controlled Substances Act.
Support H.R. 5227, the LIFT the BAR Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Support H.R. 4812/S. 2570, the Border Health Security Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Support H.R. 4583/S. 2413, the Supporting Positive Outcomes After Release Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |